Skip to main content
Avidity Biosciences, Inc. (RNAM)
Feb 27, 2026 - RNAM was delisted (reason: acquired by NVS)
71.36
0.00 (0.00%)
Inactive · Last trade price on Feb 26, 2026

Avidity Biosciences Revenue

In the year 2025, Avidity Biosciences had annual revenue of $18.76M with 72.11% growth. Avidity Biosciences had revenue of $860.00K in the quarter ending December 31, 2025, a decrease of -71.07%.

Revenue (ttm)
$18.76M
Revenue Growth
+72.11%
P/S Ratio
n/a
Revenue / Employee
$36,703
Employees
511
Market Cap
n/a

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202518.76M7.86M72.11%
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNAM News

More News